Literature DB >> 19662460

Perioperative risk assessment for hepatocellular carcinoma by using the MELD score.

Spiros G Delis1, Andreas Bakoyiannis, Christos Dervenis, Nikos Tassopoulos.   

Abstract

BACKGROUND/AIMS: The aim of this study was to evaluate the ability of Model for End-Stage Liver Disease (MELD) in predicting post hepatectomy outcome for hepatocellular carcinoma (HCC).
METHODS: Between 2001 and 2005, 94 cirrhotic patients with HCC underwent hepatectomy and were analyzed retrospectively. MELD score associated with postoperative mortality and morbidity, hospital stay, and 3-year survival.
RESULTS: Twenty-eight major and 66 minor resections were performed. Thirty-day mortality rate was 6.4%. MELD <or= 9 was associated with no perioperative mortality vs 15.3% when MELD > 9 (p = 0.01). Overall morbidity rate was 32%; 21% when MELD <or= 9 vs 42% when MELD > 9 (p = 0.01). Median hospital stay was 11 days (7 days, when MELD <or= 9 and 14 days when MELD > 9; p = 0.03). Three-year survival reached 48% (63% when MELD <or= 9; 30% when MELD > 9; p < 0.01). In multivariate analysis, MELD > 9 (p = 0.01), clinical tumor symptoms (p = 0.04), and American Society of Anesthesiologists score (p = 0.04) were independent predictors of perioperative mortality; MELD > 9 (p = 0.01), tumor size >5 cm (p = 0.01), presence of tumor symptoms (p = 0.02), high tumor grade (p = 0.01), and absence of tumor capsule (p = 0.01) were independent predictors of decreased long-term survival.
CONCLUSION: MELD score seems to predict outcome of cirrhotic patients with HCC after hepatectomy.

Entities:  

Mesh:

Year:  2009        PMID: 19662460     DOI: 10.1007/s11605-009-0977-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  41 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

2.  Natural killer cell activity in alcoholic cirrhosis: influence of nutrition.

Authors:  F Ledesma; S Echevarria; F Casafont; J L Lozano; F Pons-Romero
Journal:  Eur J Clin Nutr       Date:  1990-10       Impact factor: 4.016

3.  The lidocaine (MEGX) test as an index of hepatic function: its clinical usefulness in liver surgery.

Authors:  G Ercolani; G L Grazi; R Callivà; F Pierangeli; M Cescon; A Cavallari; A Mazziotti
Journal:  Surgery       Date:  2000-04       Impact factor: 3.982

Review 4.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

5.  Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value.

Authors:  G L Grazi; G Ercolani; F Pierangeli; M Del Gaudio; M Cescon; A Cavallari; A Mazziotti
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

6.  Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis.

Authors:  D Franco; L Capussotti; C Smadja; H Bouzari; J Meakins; F Kemeny; D Grange; M Dellepiane
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

7.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

8.  The survival benefit of liver transplantation.

Authors:  Robert M Merion; Douglas E Schaubel; Dawn M Dykstra; Richard B Freeman; Friedrich K Port; Robert A Wolfe
Journal:  Am J Transplant       Date:  2005-02       Impact factor: 8.086

9.  Predictive indices of morbidity and mortality after liver resection.

Authors:  Rebecca A Schroeder; Carlos E Marroquin; Barbara Phillips Bute; Shukri Khuri; William G Henderson; Paul C Kuo
Journal:  Ann Surg       Date:  2006-03       Impact factor: 12.969

10.  Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality.

Authors:  Swee H Teh; John Christein; John Donohue; Florencia Que; Michael Kendrick; Michael Farnell; Stephen Cha; Patrick Kamath; Raymond Kim; David M Nagorney
Journal:  J Gastrointest Surg       Date:  2005-12       Impact factor: 3.267

View more
  10 in total

Review 1.  Defining Post Hepatectomy Liver Insufficiency: Where do We stand?

Authors:  Kelly Lafaro; Stefan Buettner; Hadia Maqsood; Doris Wagner; Fabio Bagante; Gaya Spolverato; Li Xu; Ihab Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-06-11       Impact factor: 3.452

2.  Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients.

Authors:  Masaya Sato; Ryosuke Tateishi; Hideo Yasunaga; Hiromasa Horiguchi; Haruhiko Yoshida; Shinya Matsuda; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2012-03-17       Impact factor: 7.527

3.  Pre-operative nomogram to predict risk of peri-operative mortality following liver resections for malignancy.

Authors:  Mashaal Dhir; Lynette M Smith; Fred Ullrich; Premila D Leiphrakpam; Quan P Ly; Aaron R Sasson; Chandrakanth Are
Journal:  J Gastrointest Surg       Date:  2010-09-08       Impact factor: 3.452

Review 4.  Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patients.

Authors:  Alessandro Cucchetti; Matteo Cescon; Franco Trevisani; Antonio Daniele Pinna
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

5.  Can the model for end-stage liver disease score replace the indocyanine green clearance test in the selection of right hemihepatectomy in Child-Pugh class A?

Authors:  Jong Man Kim; Choon Hyuck David Kwon; Jae-Won Joh; Jae Berm Park; Joon Hyeok Lee; Gaab Soo Kim; Sung Joo Kim; Seung Woon Paik
Journal:  Ann Surg Treat Res       Date:  2014-02-24       Impact factor: 1.859

6.  RAM score is an effective predictor for early mortality and recurrence after hepatectomy for hepatocellular carcinoma.

Authors:  Heng-Yuan Hsu; Ming-Chin Yu; Chao-Wei Lee; Hsin-I Tsai; Chang-Mu Sung; Chun-Wei Chen; Shu-Wei Huang; Cheng-Yu Lin; Wen-Juei Jeng; Wei-Chen Lee; Miin-Fu Chen
Journal:  BMC Cancer       Date:  2017-11-09       Impact factor: 4.430

7.  A simple scoring system to estimate perioperative mortality following liver resection for primary liver malignancy-the Hepatectomy Risk Score (HeRS).

Authors:  Dimitrios Moris; Brian I Shaw; Cecilia Ong; Ashton Connor; Mariya L Samoylova; Samuel J Kesseli; Nader Abraham; Jared Gloria; Robin Schmitz; Zachary W Fitch; Bryan M Clary; Andrew S Barbas
Journal:  Hepatobiliary Surg Nutr       Date:  2021-06       Impact factor: 7.293

Review 8.  Surgical Treatment of Hepatocellular Carcinoma.

Authors:  Daniel Zamora-Valdes; Timucin Taner; David M Nagorney
Journal:  Cancer Control       Date:  2017 Jul-Sep       Impact factor: 3.302

9.  A nomogram for prediction of posthepatectomy liver failure in patients with hepatocellular carcinoma: A retrospective study.

Authors:  Yi-Nan Shen; Tian-Yu Tang; Wei-Yun Yao; Cheng-Xiang Guo; Wei Song; Ting-Bo Liang; Xue-Li Bai
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

10.  A Nomogram Based on Preoperative Inflammatory Indices and ICG-R15 for Prediction of Liver Failure After Hepatectomy in HCC Patients.

Authors:  Tongdi Fang; Guo Long; Dong Wang; Xudong Liu; Liang Xiao; Xingyu Mi; Wenxin Su; Liuying Zhou; Ledu Zhou
Journal:  Front Oncol       Date:  2021-07-02       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.